Recall, testing inquiry
This article was originally published in The Tan Sheet
Executive Summary
The House Energy and Commerce Oversight and Investigations Subcommittee asks food firms about microbiological and chemical contamination during food processing. In May 8 letters, the subcommittee asks firms including Procter & Gamble and the Campbell Soup Company to list and explain their recalls and food safety alerts and, if applicable, list the contaminants involved. The subcommittee also asks for microbiological testing information that returned positive results, whether firms notified FDA if there was a chemical or contaminant issue and if and when the firms denied FDA or another regulatory agency access to records or facilities that involved testing methods. The committee asks firms to respond with domestic production information within two business weeks of receiving the letter, and to provide international production information within four weeks...
You may also be interested in...
EU Experts Want One-Stop-Shop EU Governance That Mimics Best Of Other Jurisdictions
It may be blue sky thinking to surmise how a new EU medtech regulatory governance structure could evolve. But with change on the horizon, experts see exciting opportunities.
How Ochre Bio Bagged Boehringer For Its RNA-Based Regenerative MASH Therapies
UK-based Ochre Bio has signed its first major deal with Boehringer Ingelheim. Scrip talked to its co-founder and CEO, Jack O’Meara, about its human tissue-based drug discovery platform, its resulting RNA platform for liver disease and how the fledgling drug company's early work mirrored that seen in diagnostics.
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.